middle.news

How Is Emyria Delivering Lasting Relief for Treatment-Resistant PTSD Patients?

1:32am on Monday 2nd of June, 2025 AEST Healthcare
Read Story

How Is Emyria Delivering Lasting Relief for Treatment-Resistant PTSD Patients?

1:32am on Monday 2nd of June, 2025 AEST
Key Points
  • 63% of patients no longer meet PTSD diagnostic criteria at six months
  • Average 55.5% reduction in PTSD symptom severity sustained
  • 121.5% improvement in quality-of-life scores reported
  • Non-binding MOU signed with ANU for research and clinician training
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Emyria (ASX:EMD)
OPEN ARTICLE